ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
96,344.27
-0.89%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Australian Clinical Labs Limited (ACL) Share Price

Australian Clinical Labs Limited

Australian Clinical Labs Limited (ACL)

ASX
3.43
-0.06
(-1.72%)
Closed December 22 11:00PM
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.43
Bid
3.36
Ask
3.47
Volume
557,390
3.35 Day's Range 3.45
2.14 52 Week Range 3.855
Market Cap
692.291M
Previous Close
3.49
Open
3.45
Last Trade
1
@
3.44
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
791,333
Shares Outstanding
201,834,015
Dividend Yield
-
PE Ratio
28.92
Earnings Per Share (EPS)
0.12
Revenue
697.54M
Net Profit
23.93M

About Australian Clinical Labs Limited

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
clinicallabs.com.au/offer
Headquarters
Melbourne, Victoria, Aus
Founded
-
Australian Clinical Labs Limited is listed in the Medical Laboratories sector of the Australian Stock Exchange with ticker ACL. The last closing price for Australian Clinical Labs was AUD3.49. Over the last year, Australian Clinical Labs shares have traded in a share price range of AUD 2.14 to AUD 3.855.

Australian Clinical Labs currently has 201,834,015 shares outstanding. The market capitalization of Australian Clinical Labs is AUD704.40 million. Australian Clinical Labs has a price to earnings ratio (PE ratio) of 28.92.

Ask ADVFN Intelligence (AI)

ACL Latest News

More News

Alchemia Limited slammed 53%: Is the stock a buy?

http://www.fool.com.au/2015/05/29/alchemia-limited-slammed-53-is-the-stock-a-buy/

May 29 2015
The Motley Fool

Alchemia Announces Initiation of Phase II Trial in Small Cell Lung Cancer

Alchemia Limited (ASX:ACL), today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC...

September 12 2011
Business Wire

UPDATE: Dr Reddy's Gets US OK For Generic Anticlotting Injection

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received U.S. regulatory approval to launch a copy of GlaxoSmithKline PLC's (GSK) anticlotting Arixtra injection, which is expected...

July 13 2011
Dow Jones News

Dr. Reddy’s Announces the USFDA Approval of Fondaparinux Sodium Injection

Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final approval of Dr. Reddy’s ANDA for...

July 13 2011
Business Wire

Dr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood Clots

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received final approval from the U.S. Food and Drug Administration to sell a generic version of GlaxoSmithKline PLC's (GSK) Arixtra...

July 13 2011
Dow Jones News

Alchemia to Present at Cowen and Company 31st Annual Health Care Conference

Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update at the Cowen and Company 31st Annual Health Care...

March 04 2011
Business Wire

Alchemia and Dr Reddy’s Expand Fondaparinux Marketing Collaboration

Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection (the generic version of GlaxoSmithKline’s...

July 14 2010
Business Wire

Alchemia’s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer

Alchemia’s (ASX: ACL) subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The...

April 20 2010
Business Wire

Emisphere Technologies and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen® Technology

Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug...

March 18 2010
Business Wire

CORRECT: Alcon 3Q Profit Down 18%, Raises 2009 Earnings View

("Alcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd Time," published at 6:12 p.m. EDT, incorrectly included a tax benefit for the latest quarter. The correct version follows.) DOW JONES...

October 27 2009
Dow Jones News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.2923976608193.423.633.353714993.54361324DE
4-0.01-0.2906976744193.443.83.355241863.54579352DE
12-0.22-6.027397260273.653.8553.297913333.60951027DE
260.8432.43243243242.593.8552.2510330713.10268179DE
520.5920.77464788732.843.8552.147786502.93295196DE
156-1.56-31.26252505014.996.392.147140683.57535729DE
2603.41931081.81818180.0116.390.0117059043.65478367DE

ACL - Frequently Asked Questions (FAQ)

What is the current Australian Clinical Labs share price?
The current share price of Australian Clinical Labs is AUD 3.43
How many Australian Clinical Labs shares are in issue?
Australian Clinical Labs has 201,834,015 shares in issue
What is the market cap of Australian Clinical Labs?
The market capitalisation of Australian Clinical Labs is AUD 704.4M
What is the 1 year trading range for Australian Clinical Labs share price?
Australian Clinical Labs has traded in the range of AUD 2.14 to AUD 3.855 during the past year
What is the PE ratio of Australian Clinical Labs?
The price to earnings ratio of Australian Clinical Labs is 28.92
What is the cash to sales ratio of Australian Clinical Labs?
The cash to sales ratio of Australian Clinical Labs is 0.99
What is the reporting currency for Australian Clinical Labs?
Australian Clinical Labs reports financial results in AUD
What is the latest annual turnover for Australian Clinical Labs?
The latest annual turnover of Australian Clinical Labs is AUD 697.54M
What is the latest annual profit for Australian Clinical Labs?
The latest annual profit of Australian Clinical Labs is AUD 23.93M
What is the registered address of Australian Clinical Labs?
The registered address for Australian Clinical Labs is 1868-1892 DANDENONG ROAD, CLAYTON, MELBOURNE, VICTORIA, 3168
What is the Australian Clinical Labs website address?
The website address for Australian Clinical Labs is clinicallabs.com.au/offer
Which industry sector does Australian Clinical Labs operate in?
Australian Clinical Labs operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ODEOOdessa Minerals Ltd
AUD 0.002
(100.00%)
500k
LM1Leeuwin Metals Ltd
AUD 0.10
(66.67%)
468.95k
RADORadiopharm Theranostics Ltd
AUD 0.008
(60.00%)
200k
PKOPeako Limited
AUD 0.003
(50.00%)
166.67k
ENVOEnova Mining Ltd
AUD 0.003
(50.00%)
250k
JAYJayride Group Limited
AUD 0.003
(-40.00%)
5.13M
CZNCorazon Mining Ltd
AUD 0.002
(-33.33%)
7.71M
1AIOAlgorae Pharmaceuticals Ltd
AUD 0.002
(-33.33%)
1.55M
GTRGTI Energy Ltd
AUD 0.003
(-25.00%)
5.68M
TTITraffic Technologies Ltd
AUD 0.003
(-25.00%)
4.6M
VAUVault Minerals Ltd
AUD 0.325
(-1.52%)
52.89M
EVNEvolution Mining Ltd
AUD 4.80
(0.00%)
38.65M
RSGResolute Mining Limited
AUD 0.4025
(0.63%)
37.61M
SYASayona Mining Limited
AUD 0.0255
(4.08%)
36.86M
MSBMesoblast Limited
AUD 2.40
(-21.31%)
34.45M

Discussion

View Full Feed
CanItBThisEZ2Make CanItBThisEZ2Make 4 minutes ago
BEST SELLERS RANK (BSR) IS 894 69 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
gimmee greenbacks gimmee greenbacks 6 minutes ago
The Definition of a stock board Troll.

Cries like a five year old if a mention is made on that POS bag he’s holding is visited.

How ruch.

What’s good for the goose is good for the gander..



BIEL
BIEL
Not likely Not likely 6 minutes ago
I'm addictive with you folk.
SPZI
coccyx coccyx 6 minutes ago
Wow, the desperation is astounding.

Kool Aid Man and I-Glow, you’re both throwing out BS takes without understanding how Bloxcross operates or how SPZI reports its numbers. I'm sure it was intentional.

First, Bloxcross generates revenue by facilitating global transactio
SPZI
sylvia07 sylvia07 11 minutes ago
It's very telling, why they are here everyday for years, its not out of the goodness of their hearts!
DBMM
rx7171 rx7171 16 minutes ago
This is not true.
The MAA if approved allows the drug to be marketed in all the EU countries.
That is the point of the “centralized procedure”.

Type in “definition of centralized procedure in EMA MAA”.

https://www.google.com/search?q=defintion+of+centrikiz
AVXL
powerbattles powerbattles 21 minutes ago
That is sad! The stock came up on my radar today, but after doing some due diligence, I discovered they're no longer in business. This could be the next QBTS.
"The staff believes the Company no longer has an operating business and is a “public shell”.
QBTS
happyglass happyglass 23 minutes ago
Trudeau acted in the best interest of everyone and the foreign chaos agents have been using the pandemic to cause trouble. The squat was a red herring. I know lots of truckers who did not get the shot and just got re assigned. Foreign interference and corrupted police caused problems. The actual
TLRY
jeunke22 jeunke22 24 minutes ago
For non business people and anybody else who wants to know what Lightwave’s Logic business model will look like, I recommend to keep following Universal Display Corporation and its OLED ( organic light emission display) business model.
Lebby used to refer to that model as a reference for Lig
LWLG
jimmy051357 jimmy051357 25 minutes ago
T - 8 days
SANP
Zorax Zorax 41 minutes ago
I wonder if he can type with two thumbs.
happyglass happyglass 42 minutes ago
The new administration is no friend of cannabis imo. I cannot understand why the industry prefers state by state medical over full national legalization. It effectively breaks the market up into 50 little countries and the largest market is limited to 34 million people. That is why I am sticking
OILFF
lakers17 lakers17 45 minutes ago
Some crypto AI thoughts (turn on the volume)

https://x.com/i/status/1870619996684185975
MoneyMaker111 MoneyMaker111 54 minutes ago
$30B+ worth of Archegos swaps expiring (January)

Legacy Bill Hwang short positions in $GME.

UBS absorbed Archegos/Credit Suisse's $GME-short bags.

Look out! This is big. Current administration may have pushed this out to impact the next administration t
GME
awesomed007 awesomed007 55 minutes ago
I thought put you on ignore, lol.
SPZI
copytele copytele 57 minutes ago
RGTI
RGTI
Chiugray Chiugray 58 minutes ago
Nice.
NWBO
copytele copytele 1 hour ago
GAVE YOU # 25
RGTI
Zorax Zorax 1 hour ago
The reality is shitface offered him a deal he couldn't refuse. A government job.
ReasearchThis ReasearchThis 1 hour ago
I really think AXXA Bashers should study in detail.
AXXA's new business plan. In quotes
AXXA has been
"Grossly overlooked
Formally updated company kickbacks
Yearly outstanding updated receipts
Systematically experiencing lasting financials"
AXXA
Think1st Think1st 1 hour ago
https://finance.yahoo.com/news/exclusive-u-data-center-power-150910487.html
LWLG

Your Recent History

ASX
ACL
Australian Clinical Labs
LSE
SX81
Sant Uk 28
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads